Published March 2007 | Version v1
Journal article

Research advances in carrier of radioimmunotherapy

Creators

  • 1. Immunology Department, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Beijing Union Medical College, Tianjin (China)

Description

Radioimmunotherapy is a new method using nuclid targeting therapy, which utilizing monoclonal antibody labeled nuclid bindes to molecule expressing on carcinoma cell specificitilly. With improving in carrier of nuclid, radioimmunotherapy is more and more consummate, it will have higher value in use in diagnosis and therapy of diseases. (authors)

Additional details

Publishing Information

Journal Title
International Journal of Radiation Medicine and Nuclear Medicine
Journal Volume
31
Journal Issue
2
Journal Page Range
p. 77-79
ISSN
1673-4114

INIS

Country of Publication
China
Country of Input or Organization
China
INIS RN
40041056
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CARCINOMAS; CARRIERS; DIAGNOSIS; MOLECULES; MONOCLONAL ANTIBODIES; RADIOIMMUNOTHERAPY
Descriptors DEC
ANTIBODIES; DISEASES; IMMUNOTHERAPY; MEDICINE; NEOPLASMS; NUCLEAR MEDICINE; RADIOLOGY; RADIOTHERAPY; THERAPY

Optional Information

Notes
13 refs.